Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice
- 1 August 2010
- journal article
- research article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 80 (3), 352-361
- https://doi.org/10.1016/j.bcp.2010.04.014
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education
This publication has 55 references indexed in Scilit:
- Alisol B acetate induces apoptosis of SGC7901 cells via mitochondrial and phosphatidylinositol 3-kinases/Akt signaling pathwaysWorld Journal of Gastroenterology, 2009
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4Journal of Cell Science, 2007
- Coordination of microtubules and the actin cytoskeleton is important in osteoclast function, but calcitonin disrupts sealing zones without affecting microtubule networksBone, 2006
- Nuclear Factor of Activated T Cells c1 Induces Osteoclast-associated Receptor Gene Expression during Tumor Necrosis Factor-related Activation-induced Cytokine-mediated OsteoclastogenesisJournal of Biological Chemistry, 2005
- Anti-complementary activity of protostane-type triterpenes fromAlismatis rhizomaArchives of Pharmacal Research, 2003
- Osteoclast differentiation and activationNature, 2003
- Tartrate-Resistant Acid Phosphatase 5b: A Novel Serum Marker of Bone ResorptionJournal of Bone and Mineral Research, 2000
- Characterization of the Intracellular Domain of Receptor Activator of NF-κB (RANK)Journal of Biological Chemistry, 1998
- Microcirculation and traditional Chinese medicineJAMA, 1988